AST Announces Quick Delivery For GENiSYS® C R&D Small Batch cGMP Filling & Closing System

Available for quick delivery, AST's Isolated GENiSYS® C is a fully integrated solution for the production of high-value liquid pharmaceuticals. Designed in collaboration with Germfree, and leveraging the latest American-made turnkey technology from AST, this production system is backed by a localized, responsive model for supply and service.

The Isolated GENiSYS C is outfitted with AST's Atmos isolator, which features groundbreaking low-concentration hydrogen peroxide technology from CURIS System. This innovative low-volume, 7% Vapor Phase H2O2 solution utilizes patented Pulse™ technology for automated, precise bio-decontamination protocols proven to achieve repeatable 6-log reduction or better. Utilizing the only 7% VPHP system to be federally approved via tri-part soil load, AST's barrier technology combines validated efficacy with complete cycle times (including aeration) of under 60 minutes.

The new Atmos isolator and the latest-generation GENiSYS C are two of AST's intuitive, compact solutions that prioritize maximum yield and end-to-end product stewardship. Designed with superior flexibility and ultimate efficiency, these products are built to meet the multi-modal requirements of many of today's parenteral drug manufacturers looking to keep their operational footprint small and their drug development process agile.

Highlights include:

• Available for 6-month delivery
• Processes vials, syringes, and cartridges with minimal changeover time
• Flexible, compact isolator design
• 100-percent integration of fill-finish and barrier systems
• State-of-the-art automation
• Industry-leading bio decontamination cycle times

Please contact AST to discuss further